Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, T.
Right arrow Articles by Nagawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, T.
Right arrow Articles by Nagawa, H.
[Cancer Research 66, 3370-3374, April 1, 2006]
© 2006 American Association for Cancer Research


Priority Reports

Prediction of Sensitivity of Rectal Cancer Cells in Response to Preoperative Radiotherapy by DNA Microarray Analysis of Gene Expression Profiles

Toshiaki Watanabe1, Yasuhiro Komuro1, Tomomichi Kiyomatsu1, Takamitsu Kanazawa1, Yoshihiro Kazama1, Junichiro Tanaka1, Toshiaki Tanaka1, Yoko Yamamoto1, Masatoshi Shirane2, Tetsuichiro Muto3 and Hirokazu Nagawa1

1 Department of Surgical Oncology, University of Tokyo Hospital, Hongo, Bunkyo-ku, Tokyo, Japan; 2 Product Research Department, Chugai Pharmaceutical Co. Ltd., Kajiwara, Kamakura, Kanagawa, Japan; and 3 The Cancer Institute Hospital of JFCR, Ariake, Kotoh-ku, Tokyo, Japan

Requests for reprints: Toshiaki Watanabe, Department of Surgical Oncology, University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Phone: 81-3-5800-8653; Fax: 81-3-3811-6822; E-mail: toshwatanabe{at}yahoo.co.jp.

Preoperative radiotherapy has been widely used to improve local control of disease and to improve survival in the treatment of rectal cancer. However, the response to radiotherapy differs among individual tumors. Our objective here was to identify a set of discriminating genes that can be used for characterization and prediction of response to radiotherapy in rectal cancer. Fifty-two rectal cancer patients who underwent preoperative radiotherapy were studied. Biopsy specimens were obtained from rectal cancer before preoperative radiotherapy. Response to radiotherapy was determined by histopathologic examination of surgically resected specimens and classified as responders or nonresponders. By determining gene expression profiles using human U95Av2 Gene Chip, we identified 33 novel discriminating genes of which the expression differed significantly between responders and nonresponders. Using this gene set, we were able to establish a new model to predict response to radiotherapy in rectal cancer with an accuracy of 82.4%. The list of discriminating genes included growth factor, apoptosis, cell proliferation, signal transduction, or cell adhesion–related genes. Among 33 discriminating genes, apoptosis inducers (lumican, thrombospondin 2, and galectin-1) showed higher expression in responders whereas apoptosis inhibitors (cyclophilin 40 and glutathione peroxidase) showed higher expression in nonresponders. The present study suggested the possibility that gene expression profiling may be useful in predicting response to radiotherapy to establish an individualized tailored therapy for rectal cancer. Global expression profiles of responders and nonresponders may provide insights into the development of novel therapeutic targets. (Cancer Res 2006; 66(7): 3370-4)




This article has been cited by other articles:


Home page
Arch SurgHome page
B. S. Min, Y. J. Choi, H. R. Pyo, H. Kim, J. Seong, H. C. Chung, S. Y. Rha, and N. K. Kim
Cyclooxygenase-2 Expression in Pretreatment Biopsy as a Predictor of Tumor Responses After Preoperative Chemoradiation in Rectal Cancer
Arch Surg, November 1, 2008; 143(11): 1091 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Hong, K. S. Ho, K. W. Eu, and P. Y. Cheah
A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis
Clin. Cancer Res., February 15, 2007; 13(4): 1107 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Watanabe, T. Kobunai, E. Toda, T. Kanazawa, Y. Kazama, J. Tanaka, T. Tanaka, Y. Yamamoto, K. Hata, T. Kojima, et al.
Gene Expression Signature and the Prediction of Ulcerative Colitis-Associated Colorectal Cancer by DNA Microarray
Clin. Cancer Res., January 15, 2007; 13(2): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Watanabe, T. Kobunai, E. Toda, Y. Yamamoto, T. Kanazawa, Y. Kazama, J. Tanaka, T. Tanaka, T. Konishi, Y. Okayama, et al.
Distal Colorectal Cancers with Microsatellite Instability (MSI) Display Distinct Gene Expression Profiles that Are Different from Proximal MSI Cancers
Cancer Res., October 15, 2006; 66(20): 9804 - 9808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.